首页> 外文期刊>Bioorganic and medicinal chemistry >Conformationally rigid N-acyl-5-alkyl-L-prolyl-pyrrolidines as prolyl oligopeptidase inhibitors.
【24h】

Conformationally rigid N-acyl-5-alkyl-L-prolyl-pyrrolidines as prolyl oligopeptidase inhibitors.

机译:构型刚性的N-酰基-5-烷基-L-脯氨酰基-吡咯烷酮作为脯氨酰寡肽酶抑制剂。

获取原文
获取原文并翻译 | 示例
           

摘要

In the N-acyl-L-prolyl-pyrrolidine type of prolyl oligopeptidase inhibitors the L-prolyl group was replaced by different 5-alkyl-L-prolyl groups, resulting in a series of N-acyl-5-alkyl-L-prolyl-pyrrolidines. Since N-amides of 5-alkyl-L-prolines are conformationally more rigid than those of L-proline, the main objective was to make more rigid prolyl oligopeptidase inhibitors. In the series of compounds where the N-acyl group was a Boc group, the 5(R)-tert-butyl group increased the potency strongly. A similar effect was not observed for the 5(S)-tert-butyl group. In the series of compounds where the N-acyl group was a 4-phenylbutanoyl group, the 5(R)-tert-butyl, 5(R)-methyl and 5(S)-methyl groups did not have an effect on the potency [the 5(S)-tert-butyl group was not tested in this series]. As an additional effect, the 5-tert-butyl groups increased the log P of the compounds 1.5 log units, which might be beneficial when targeting the compounds to the brain.
机译:在N-酰基-L-脯氨酰基-吡咯烷类型的脯氨酰寡肽酶抑制剂中,L-脯氨酰基被不同的5-烷基-L-脯氨酰基取代,产生了一系列N-酰基-5-烷基-L-脯氨酰基-吡咯烷。由于5-烷基-L-脯氨酸的N-酰胺在构象上比L-脯氨酸更坚硬,因此主要目的是制造更坚硬的脯氨酰寡肽酶抑制剂。在N-酰基为Boc基团的一系列化合物中,5(R)-叔丁基基团大大提高了效力。对于5(S)-叔丁基没有观察到类似的效果。在N-酰基为4-苯基丁酰基的一系列化合物中,5(R)-叔丁基,5(R)-甲基和5(S)-甲基对效力没有影响[该系列未测试5(S)-叔丁基]。另外,5-叔丁基可将化合物的log P增加1.5 log个单位,这在将化合物靶向大脑时可能是有益的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号